Earnings Call · Q3 FY2022·2022-11-16

Q3 22EPS -76.56%·Rev n/aQ2 22EPS -100.00%*·Rev n/aQ1 22EPS +40.91%·Rev n/aQ4 21EPS -73.33%·Rev n/a⚠ consensus missing

BIO KEY INTERNATIONAL INC BKYI

Kimberly Johnson — Investor Relations or Communications (inferred from context)

Michael DePasquale — Chairman and Chief Executive Officer (CEO)

Alex Rocha — Managing Director of BIO-key EMEA

Cecilia Welch — Chief Financial Officer (CFO)

−23.7%1d on move date−24.6% vs SPY3d−34.6%5d−35.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BKYI calls or request research access.

More BKYI calls Browse calls Request research access